Clinical Study Results
Where can I learn more about this study?
You can find more information about this study on the websites listed below. If a full report
of the study results is available, it can also be found here.
• www.clinicaltrials.gov. Once you are on the website, type “NCT03235375” into the
“Other Terms” search box and click “Search”.
• www.AstraZenecaClinicalTrials.com. Once you are on the website, type
“D5670C00008” into the search box, and click “Find a Study”.
Full study title: A Phase 1, Open-Label, Single Dose, Parallel-Group Study to Evaluate
the Pharmacokinetics, Safety and Tolerability of MEDI0382 in Subjects with Renal
Impairment
MedImmune Protocol number: D5670C00008
MedImmune, Ltd., a member of the AstraZeneca Group, sponsored this study and has its
headquarters at 1 Medimmune Way, Gaithersburg, MD 20878.
The phone number for the AstraZeneca Information Center is +1-877-240-9479.
Thank you!
Clinical study participants belong to a large community of people who take part in
clinical research around the world. They help researchers answer important health
questions and find medical treatments for participants.
The Center for Information & Study on Clinical Research
Participation (CISCRP) is a non-profit organization
focused on educating and informing the public about
clinical research participation. CISCRP is not involved
in recruiting patients for clinical studies, nor is it
involved in conducting clinical studies.
CISCRP
One Liberty Square, Suite 1100
Boston, MA 02109
1-877-MED-HERO
www.ciscrp.org
8
Version 1.3 2019_02_12